Spyre Therapeutics (SYRE) Amortizatization of Intangibles (2015 - 2026)
Spyre Therapeutics posted quarterly Amortizatization of Intangibles of $2.1 million for Q1 2026, down 22.07% year-on-year from $2.6 million in Q1 2025, and up 134.29% on a QoQ basis from -$6.0 million in Q4 2025.
Spyre Therapeutics (SYRE) has 12 years of Amortizatization of Intangibles data on file, last reported at $2.1 million in Q1 2026.
- For the quarter ending Q1 2026, Amortizatization of Intangibles fell 22.07% year-over-year to $2.1 million; the trailing twelve-month figure through Mar 2026 stood at -$583000.0 (down 105.02% YoY), and the FY2024 full-year result was $11.4 million, up 5083.64% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $2.1 million, up from -$6.0 million in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $3.6 million in Q2 2024 and bottomed at -$6.0 million in Q4 2025.
- The 5-year median for Amortizatization of Intangibles is $809500.0 (2022), against an average of $880000.0.
- The widest annual swing landed in 2024, when Amortizatization of Intangibles surged 22156.25%; it then sank 348.24% in 2025.
- A 5-year view of Amortizatization of Intangibles shows it stood at $105000.0 in 2022, then declined by 7.62% to $97000.0 in 2023, then surged by 2393.81% to $2.4 million in 2024, then tumbled by 348.24% to -$6.0 million in 2025, then surged by 134.29% to $2.1 million in 2026.
- The last three Amortizatization of Intangibles figures came in at $2.1 million (Q1 2026), -$6.0 million (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Spyre Therapeutics | 5.55 Bn | 5.55 Bn | - | 2.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.06 Mn |
| Mar 31, 2026 | 2.06 Mn |
| Dec 31, 2025 | -6.01 Mn |
| Dec 31, 2025 | -6.01 Mn |
| Sep 30, 2025 | 1.35 Mn |
| Sep 30, 2025 | 1.35 Mn |
| Jun 30, 2025 | 2.01 Mn |
| Jun 30, 2025 | 2.01 Mn |
| Mar 31, 2025 | 2.64 Mn |
| Mar 31, 2025 | 2.64 Mn |
| Dec 31, 2024 | 2.42 Mn |
| Dec 31, 2024 | 2.42 Mn |
| Sep 30, 2024 | 3.00 Mn |
| Sep 30, 2024 | 3.00 Mn |
| Jun 30, 2024 | 3.56 Mn |
| Jun 30, 2024 | 3.56 Mn |
| Mar 31, 2024 | 2.42 Mn |
| Mar 31, 2024 | 2.42 Mn |
| Sep 30, 2023 | 97,000.00 |
| Sep 30, 2023 | 97,000.00 |
| Jun 30, 2023 | 16,000.00 |
| Jun 30, 2023 | 16,000.00 |
| Mar 31, 2023 | 107,000.00 |
| Mar 31, 2023 | 107,000.00 |
| Dec 31, 2022 | 105,000.00 |
| Dec 31, 2022 | 105,000.00 |
| Sep 30, 2022 | 269,000.00 |
| Sep 30, 2022 | 269,000.00 |
| Jun 30, 2022 | 38,000.00 |
| Jun 30, 2022 | 38,000.00 |
| Mar 31, 2022 | -15,000.00 |
| Mar 31, 2022 | -15,000.00 |
| Dec 31, 2021 | -58,000.00 |
| Dec 31, 2021 | -58,000.00 |
| Sep 30, 2021 | -149,000.00 |
| Sep 30, 2021 | -149,000.00 |
| Jun 30, 2021 | -160,000.00 |
| Jun 30, 2021 | -160,000.00 |
| Mar 31, 2021 | -181,000.00 |
| Mar 31, 2021 | -181,000.00 |
| Dec 31, 2020 | -120,000.00 |
| Dec 31, 2020 | -120,000.00 |
| Sep 30, 2020 | -11,000.00 |
| Sep 30, 2020 | -11,000.00 |
| Jun 30, 2020 | 10,000.00 |
| Jun 30, 2020 | 10,000.00 |
| Mar 31, 2020 | 48,000.00 |
| Mar 31, 2020 | 48,000.00 |
| Dec 31, 2019 | 69,000.00 |
| Dec 31, 2019 | 69,000.00 |
| Sep 30, 2019 | 206,000.00 |
| Sep 30, 2019 | 206,000.00 |
| Jun 30, 2019 | 268,000.00 |
| Jun 30, 2019 | 268,000.00 |
| Mar 31, 2019 | 275,000.00 |
| Mar 31, 2019 | 275,000.00 |
| Dec 31, 2018 | 282,000.00 |
| Dec 31, 2018 | 282,000.00 |
| Sep 30, 2018 | 204,000.00 |
| Sep 30, 2018 | 204,000.00 |
| Jun 30, 2018 | 93,000.00 |
| Jun 30, 2018 | 93,000.00 |
| Mar 31, 2018 | 14,000.00 |
| Mar 31, 2018 | 14,000.00 |
| Dec 31, 2017 | 7,000.00 |
| Dec 31, 2017 | 7,000.00 |
| Sep 30, 2017 | -2,000.00 |
| Sep 30, 2017 | -2,000.00 |
| Jun 30, 2017 | -129,000.00 |
| Jun 30, 2017 | -129,000.00 |
| Mar 31, 2017 | 49,000.00 |
| Mar 31, 2017 | 49,000.00 |
| Dec 31, 2016 | -152,000.00 |
| Dec 31, 2016 | -152,000.00 |
| Sep 30, 2016 | 37,000.00 |
| Sep 30, 2016 | 37,000.00 |
| Jun 30, 2016 | 6,000.00 |
| Jun 30, 2016 | 6,000.00 |
| Mar 31, 2016 | 8,000.00 |
| Mar 31, 2016 | 8,000.00 |
| Dec 31, 2015 | 1,000.00 |
| Dec 31, 2015 | 1,000.00 |